Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak

Traditionally, drug discovery utilises a de novo design approach, which requires high cost and many years of drug development before it reaches the market. Novel drug development does not always account for orphan diseases, which have low demand and hence low-profit margins for drug developers. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Zheng Yao, Farouk, Isra Ahmad, Lal, Sunil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551028/
https://www.ncbi.nlm.nih.gov/pubmed/32972027
http://dx.doi.org/10.3390/v12091058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551028/
https://www.ncbi.nlm.nih.gov/pubmed/32972027
http://dx.doi.org/10.3390/v12091058

Ejemplares similares